STOCK TITAN
  1. Home
  2. Sec-filings
  3. ONC
  4. [144] BeOne Medicines Ltd. SEC Filing

Oncosec (ONC) filer Chan Lee plans Rule 144 sale of 718,718 ADS

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Chan Lee has filed to sell shares of Oncosec Medical Incorporated under Rule 144. The planned transaction covers 718,718 American Depositary Shares (ADS), acquired in 2002, to be sold through Morgan Stanley Smith Barney LLC – Executive Financial Services on the NASDAQ, with a listed event date of 08/11/2026. The filing also notes that the ADS to be sold relate to the exercise of stock options for cash.

Over the prior three months, Lee reported multiple open-market sales, including 1,044 common shares for $337,932.36 on 07/30/2026 and several ADS transactions such as 1,669 ADS for $542,425.00 on 07/22/2026, 664 ADS for $200,833.44 on 07/08/2026, and additional ADS sales in June and May 2026, some under a Rule 10b5-1 trading plan.

Positive

  • None.

Negative

  • None.
ADS planned for sale 718,718 ADS Planned Rule 144 sale through Morgan Stanley Smith Barney LLC
Planned sale date 08/11/2026 Listed transaction date for ADS sale related to stock option exercise
Year acquired 2002 Acquisition year for ADS to be sold under Rule 144
Common shares sold 1,044 shares Common stock sale on 07/30/2026
Proceeds from 07/30/2026 common sale $337,932.36 Aggregate amount for 1,044 common shares
ADS sold 07/22/2026 1,669 ADS ADS sale labeled as 10b5-1 Sales
Proceeds from 07/22/2026 ADS sale $542,425.00 Aggregate amount for 1,669 ADS
Rule 144 regulatory
"144: Securities To Be Sold"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
American Depositary Shares financial
"ADS | Morgan Stanley Smith Barney LLC Executive Financial Services"
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.
10b5-1 Sales regulatory
"10b5-1 Sales for CHAN LEE Aeschengraben 27 Basel"
10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.
Exercise of Stock Options financial
"Exercise of Stock Options | Issuer | | | 2002 | 08/11/2026 | Cash"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What does the ONC Form 144 filing by Chan Lee disclose?
The filing discloses that Chan Lee intends to sell 718,718 ADS of Oncosec Medical Incorporated under Rule 144, with the securities acquired in 2002 and sales to be executed through Morgan Stanley Smith Barney LLC on the NASDAQ.

How many ONC ADS are planned for sale in this Form 144?
The planned sale covers 718,718 American Depositary Shares (ADS). These ADS were acquired in 2002 and are associated with the cash exercise of stock options, with the intended transaction date listed as 08/11/2026.

Which broker will handle the planned ONC Rule 144 sale for Chan Lee?
The planned Rule 144 sale will be handled by Morgan Stanley Smith Barney LLC – Executive Financial Services at 1 New York Plaza. The ADS are expected to be sold on the NASDAQ as indicated in the filing details.

What recent ONC share sales has Chan Lee reported in the last three months?
Recent activity includes 1,044 common shares sold for $337,932.36 on 07/30/2026, and ADS sales such as 1,669 ADS for $542,425.00 on 07/22/2026 and 664 ADS for $200,833.44 on 07/08/2026, plus additional ADS sales in June and May 2026.

Are Chan Lee’s recent ONC ADS sales under a Rule 10b5-1 plan?
Some of the recent ADS sales are identified as 10b5-1 Sales. For example, transactions on 07/22/2026, 07/08/2026, and 05/13/2026 are labeled as 10b5-1 Sales for Chan Lee in the transaction history.

What is the acquisition date of the ONC ADS being sold under Form 144?
The ADS to be sold under this Form 144 were acquired in 2002. The filing links these securities to the exercise of stock options for cash with a listed transaction date of 08/11/2026.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR